How a Top 10 Pharma Scaled Unified eCOA & EDC
Managing eCOA and EDC across disconnected vendors drains trial timelines with tedious Data Transfer Agreements (DTAs), weeks of manual data reconciliation, and heavy site burden. When clinical outcome assessments sit in a separate silo from clinical data, timelines drag, and the risk of data errors multiplies.
Download this case study to see how a top 10 pharma company broke this cycle across 150+ trials by deploying a unified eCOA and EDC architecture on the Medidata Platform.
You’ll discover:
- How this sponsor cut the time from Last Patient Out to database lock by an average of 2 weeks
- How unifying eCOA and EDC reduced study setup costs by 30%
- Why 80% of studies no longer required complex, time-consuming DTAs
- How real-time data access drove a 60% reduction in eCOA data change requests
- How a single interface and unified login eliminate site burden and credential fatigue
Learn how a single-platform architecture removes operational friction to accelerate your next clinical trial.